The World Health Organization (WHO) refers to obesity as abnormal or excessive fat
accumulation that presents a health risk. Obesity was first designated as a disease in 2012 …

Context: Various drugs affect body weight as a side effect. Objective: We conducted this
systematic review and meta-analysis to summarize the evidence about commonly …

Background & Aims Pharmacological management of obesity improves outcomes and
decreases the risk of obesity-related complications. This American Gastroenterological …

Background Obesity is associated with a reduction in life expectancy and an increase in
mortality from cardiovascular diseases, cancer, and other causes. We therefore assessed …

Obesity is one of the most serious and prevalent non-communicable diseases of the twenty-
first century. It is also a patient-centered condition in which affected individuals seek …

Background: Obesity is a serious chronic disease. Controlled-release phentermine/
topiramate (PHEN/TPM CR), as an adjunct to lifestyle modification, has previously shown …

A 56‐week randomized controlled trial was conducted to evaluate safety and efficacy of a
controlled‐release combination of phentermine and topiramate (PHEN/TPM CR) for weight …

Obesity is one of the most serious and prevalent non-communicable diseases of the 21st
century. It is also a patient-centered condition in which affected individuals seek treatment …

Diabetes is a growing global health concern, as is obesity. Diabetes and obesity are
intrinsically linked: obesity increases the risk of diabetes and also contributes to disease …

Objective: Our objective was to formulate practice guidelines for the treatment and
prevention of pediatric obesity. Conclusions: We recommend defining overweight as body …